Insmed Income Statement
Revenue, expenses, and profitability over time
Insmed generated $819.6M in trailing twelve-month revenue, up 1.2% year-over-year. Net income was -$1.2B with a -144.44% net margin. Gross margin stands at 81.81% and operating margin at -140.56%. Diluted EPS is $-5.74, which grew 0.0% year-over-year. Based on the Q1 2026 filing.
Latest FilingQ1 2026
Report Date2026-05-07
ROE-294.46%